ROYAL BANK OF CANADA - REPROS THERAPEUTICS INC ownership

REPROS THERAPEUTICS INC's ticker is RPRX and the CUSIP is 76028H209. A total of 64 filers reported holding REPROS THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of REPROS THERAPEUTICS INC
ValueSharesWeighting
Q3 2016$2,000
+100.0%
900
+1025.0%
0.00%
Q3 2015$1,0000.0%80
+21.2%
0.00%
Q1 2015$1,000
-99.7%
66
-99.8%
0.00%
Q3 2014$297,000
-79.8%
30,008
-62.6%
0.00%
-100.0%
Q4 2013$1,468,000
-0.4%
80,200
+45.8%
0.00%
+100.0%
Q3 2013$1,474,00055,0000.00%
Other shareholders
REPROS THERAPEUTICS INC shareholders Q2 2015
NameSharesValueWeighting ↓
SPHERA FUNDS MANAGEMENT LTD. 778,800$935,0000.18%
Allegis Investment Advisors, LLC 366,190$439,0000.12%
GENERAL AMERICAN INVESTORS CO INC 589,768$708,0000.07%
Acrospire Investment Management LLC 24,881$30,0000.02%
JACOBS LEVY EQUITY MANAGEMENT, INC 114,165$137,0000.00%
Mariner Wealth Advisors-Cincinnati, LLC 11,000$13,0000.00%
Renaissance Technologies 727,113$873,0000.00%
BALDWIN BROTHERS LLC/MA 1,750$2,0000.00%
VANGUARD GROUP INC 889,850$1,068,0000.00%
LADENBURG THALMANN FINANCIAL SERVICES INC. 150$00.00%
View complete list of REPROS THERAPEUTICS INC shareholders